Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845, Shelton, CT, August 5th, 2008
- Cara Therapeutics Secures $12.3 Million In Series C Extension Financing, July 24th 2008
- Cara Therapeutics Announces Issuance of U.S. Patent Covering Second Generation Kappa Opioid Receptor Agonists, July 22nd 2008
- Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845 , Shelton, CT, April 28th, 2008 /PRNewswire-FirstCall
- Cara Therapeutics Secures $19 Million In Series C Financing Tarrytown, NY (PRNewswire-FirstCall), November 28th, 2006
- Tripos and Cara Therapeutics Announce Medicinal Chemistry Partnership; Alliance to Address Unmet Medical Needs in the Treatment of Pain and Inflammation ST. LOUIS & BUDE, England (BUSINESS WIRE), March 22nd, 2006
- Cara Therapeutics Announces Results
of Phase 1 Clinical Trial of Novel Analgesic; CR665 Safe and Pharmacologically
Active Tarrytown, NY, July 28th, 2005
- Cara Therapeutics Initiates Clinical
Trial of Novel Pain Drug Candidate Tarrytown, NY, March 24th 2005
|
